Escitalopram vs Pembrolizumab

## Escitalopram vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Escitalopram** and **Pembrolizumab**.

## Mechanism of Action

**Escitalopram**: S-enantiomer of citalopram; selective serotonin reuptake inhibitor.

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Escitalopram — 27-32 hours; Pembrolizumab — 26 days.

## Chemical Properties

**Molecular Formula**: Escitalopram — C20H21FN2O; Pembrolizumab — N/A.

**Molecular Weight**: Escitalopram — 324.3920 g/mol; Pembrolizumab — N/A.

**Type**: Escitalopram — Small molecule; Pembrolizumab — Antibody.